Home › Funds › Seven Fleet Capital Management LP › ENTX
Seven Fleet Capital Management LP position in ENTX
ENTERA BIO LTD · Health Care
Seven Fleet Capital Management LP reported holding 6,862,744 shares of ENTX (ENTERA BIO LTD) in its Q3 2026 13F filing — a position valued at US$20.0M, representing 3.90% of its reported portfolio and ranking #5 among its reported holdings. Seven Fleet Capital Management LP has disclosed ENTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Seven Fleet Capital Management LP's ENTX position evolved
Seven Fleet Capital Management LP first disclosed a stake in ENTX in Q4 2025 at 135,318 shares (US$263K). The position peaked in Q3 2026 at 6,862,744 shares, worth US$20.0M. Across 4 filings, Seven Fleet Capital Management LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,862,744 shares valued at US$20.0M — an increase of 6,671,390 shares quarter over quarter.. Notable position changes include a 52% increase in Q1 2026 (shares rose 59% over the following quarter), a 3486% increase in Q3 2026 (shares rose 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 135.32K | $262.52K | New |
| Q1 2026 | 205.54K | $228.15K | Add |
| Q2 2026 | 191.35K | $338.70K | Reduce |
| Q3 2026 | 6.86M | $19.97M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ENTX and 13F data
ENTX (ENTERA BIO LTD) is a Health Care company. 49 other funds we track also report a position in ENTX — the largest reported positions include BVF INC/IL (US$49.6M), Vivo Capital, LLC (US$35.7M), TCG Crossover Management, LLC (US$35.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ENTX
- BVF INC/IL 17.05M sh · $49.62M · Q3 2026
- Vivo Capital, LLC 12.25M sh · $35.66M · Q3 2026
- TCG Crossover Management, LLC 12.25M sh · $35.66M · Q3 2026
- Spruce Street Capital LP 11.21M sh · $32.63M · Q3 2026
- Commodore Capital LP 7.35M sh · $21.40M · Q3 2026
- Knoll Capital Management, LLC 5.83M sh · $16.97M · Q3 2026
- Venrock Adviser, LLC 5.11M sh · $14.86M · Q3 2026
- Logos Global Management LP 4.41M sh · $12.84M · Q3 2026
- Catalio Capital Management, LP 3.92M sh · $11.41M · Q3 2026
- NEXTBio Capital Management LP 2.92M sh · $8.51M · Q3 2026
- Foresite Capital Management VI LLC 1.23M sh · $3.57M · Q3 2026
- Gem Investment Advisors, LLC 19.14K sh · $55.68K · Q3 2026
More on Seven Fleet Capital Management LP
FAQ
How long has Seven Fleet Capital Management LP held ENTX?
Seven Fleet Capital Management LP has disclosed ENTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Seven Fleet Capital Management LP's current position in ENTX?
As of Q3 2026, Seven Fleet Capital Management LP holds 6.86M shares of ENTX (ENTERA BIO LTD), valued at $19.97M, representing 3.90% of its reported portfolio and ranking #5.
Has Seven Fleet Capital Management LP been buying or selling ENTX?
In the latest 13F filing (Q3 2026), Seven Fleet Capital Management LP increased its position in ENTX. The position peaked in Q3 2026 at 6.86M shares.
Which other funds hold ENTX?
Other major institutional holders of ENTX include BVF INC/IL, Vivo Capital, LLC, TCG Crossover Management, LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.